Amdray (valspodar) - Novartis
metoclopramide - Generic mfg.
Development of fluorine-18 analogs of metoclopramide for P-gP PET imaging at the blood-brain barrier (EANM 2026) - Sep 29, 2026 - Abstract #EP-0117; "AB/BA bidirectional transport assays on transwell with MDCK-MDR1 cells overexpressing human P-gp were performed with and without P-gp inhibition by 5 µM of valspodar. Two fluorinated analogs of MTC were successfully synthesized, and in vitro experiments demonstrated that FPEG-MTC is a stronger P-gp substrate than MTC. [18F]FPEG-MTC was successfully radiosynthesized with excellent yield and molar activity for upcoming in vivo studies of the impact of P-gp inhibition on its brain distribution. These will help confirm the potential of this tracer and provide insights into its sensitivity to P-gp activity modulation, essential information for assessing its potential future applications." 
CNS Disorders • ABCB1
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
S. Huvelle 1; P. Deniel 2; B. Hosten 2; S. Chasseigneaux 3; N. Tournier 1; L. Breuil 4; F. Caillé 1
 
Sep 29, 2026
 
Prev Next